As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 31, 2015
by Louisa Frew for Science Network:
Detecting a decline in certain sensory functions may become the future of preventing Alzheimer’s disease (AD), with research showing smell testing and retinal imaging to be strong predictors of dementia risk.
Edith Cowan University Centre of Excellence for Alzheimer’s Disease Research neuroscientist and clinical psychologist Dr Hamid Sohrabi says that easy and cost-effective tools for identification of subjects in the early stages of AD is critical to improve outcomes.
“We know that memory tests are very good at identifying people who already have dementia, but we need to recognise that they are at high risk well before memory decline commences because at the latter stage the brain would be irreversibly damaged,” he says.
With clinical trials so far failing to effectively halt the progression of AD, Dr Sohrabi says scientists believe the main reason for failure is starting treatment too late when damage to the brain is too great to be reversible.
Along with work on blood biomarkers and neuropsychometric tests, Dr Sohrabi is developing a body of evidence supporting the use of smell and eye imaging assessment as predictors of future cognitive decline.
In a group of 308 46-86 year olds, the group demonstrated that poor ability to discriminate different smells significantly predicted cognitive decline at a three year follow-up.
Retinal photos identify AD sufferers
Similarly, analysis of blood vessel patterns in retinal photographs, taken as part of the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing, allowed them to correctly identify individuals with AD from healthy subjects with very high accuracy.
“There’s evidence of beta amyloid [a protein involved in the brain disease of AD] depositing in the eye—if we can detect it in the eye before it starts accumulating in the brain that may be one way of predicting who is at higher risk,” he says.
In collaboration with Dr Brett Robertson and Dr Dona Jayakody from the Ear Science Institute Australia, Dr Sohrabi will now investigate the role of hearing loss in AD prediction with the hope of a combined sensory deficit score of hearing, eye and olfactory function with strong clinical effectiveness.
“Combining the three senses may put us in the best position to predict who is at a higher risk of developing dementia due to AD,” Dr Sohrabi says.
“The best way to prevent neuropathology happening is to start finding those at higher risk, early.”
Memory loss and cognitive decline are commonly thought to be the earliest signs of the disorder, but a new study has found declines in glucose levels in the brain come even sooner. Even better? The same team...
by G.S. Mudur for The Telegraph Ashwagandha, a plant used for centuries in Ayurvedic medicine, cleaned out abnormal protein deposits in the brain and reversed damage and behavioural changes observed in Alzheimer’s disease when tested on mice, a team of...
by Karen Ravn for Dementia Today Alzheimers symptoms and signs are unique on each patient. Through that it sometimes will be tricky to diagnose Alzheimers disease. Several of the signs and symptoms present in Alzheimer’s disease also exist in other conditions...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.